These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22446020)

  • 21. RAS, BRAF, and TP53 gene mutations in Taiwanese colorectal cancer patients.
    Chang YS; Chang SJ; Yeh KT; Lin TH; Chang JG
    Onkologie; 2013; 36(12):719-24. PubMed ID: 24356563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [BRAF mutation in colorectal serrated lesions].
    Zhou ZY; Han Y; Wang LP
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3411-4. PubMed ID: 19159571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis.
    Kalady MF; Dejulius KL; Sanchez JA; Jarrar A; Liu X; Manilich E; Skacel M; Church JM
    Dis Colon Rectum; 2012 Feb; 55(2):128-33. PubMed ID: 22228154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations.
    Kim IJ; Kang HC; Jang SG; Kim K; Ahn SA; Yoon HJ; Yoon SN; Park JG
    Carcinogenesis; 2006 Mar; 27(3):392-404. PubMed ID: 16219636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
    Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
    Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Validation of Newly Developed Multiplex Kit Using Luminex xMAP Technology for Detecting Simultaneous RAS and BRAF Mutations in Colorectal Cancer: Results of the RASKET-B Study.
    Taniguchi H; Okamoto W; Muro K; Akagi K; Hara H; Nishina T; Kajiwara T; Denda T; Hironaka S; Kudo T; Satoh T; Yamanaka T; Abe Y; Fukushima Y; Yoshino T
    Neoplasia; 2018 Dec; 20(12):1219-1226. PubMed ID: 30412858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The histopathology of BRAF-V600E-mutated lung adenocarcinoma.
    Yousem SA; Nikiforova M; Nikiforov Y
    Am J Surg Pathol; 2008 Sep; 32(9):1317-21. PubMed ID: 18636014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.
    Artale S; Sartore-Bianchi A; Veronese SM; Gambi V; Sarnataro CS; Gambacorta M; Lauricella C; Siena S
    J Clin Oncol; 2008 Sep; 26(25):4217-9. PubMed ID: 18757341
    [No Abstract]   [Full Text] [Related]  

  • 29. A comprehensive procedural approach to genotyping KRAS and BRAF from paraffin embedded tissues for diagnostic purposes.
    Palmirotta R; Ludovici G; De Marchis ML; Leone B; Formica V; Ettorre GM; Cavaliere F; Della-Morte D; Ferroni P; Roselli M; Guadagni F
    In Vivo; 2012; 26(4):537-47. PubMed ID: 22773565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double
    Deshwar A; Margonis GA; Andreatos N; Barbon C; Wang J; Buettner S; Wagner D; Sasaki K; Beer A; Løes IM; Pikoulis E; Damaskos C; Garmpis N; Kamphues K; He J; Kaczirek K; Poultsides G; Lønning PE; Mischinger HJ; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    Anticancer Res; 2018 May; 38(5):2891-2895. PubMed ID: 29715113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KRAS mutational status of endoscopic biopsies matches resection specimens.
    Yang QH; Schmidt J; Soucy G; Odze R; Dejesa-Jamanila L; Arnold K; Kuslich C; Lash R
    J Clin Pathol; 2012 Jul; 65(7):604-7. PubMed ID: 22461648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation Analysis of KRAS and BRAF Genes in Metastatic Colorectal Cancer: a First Large Scale Study from Iran.
    Koochak A; Rakhshani N; Karbalaie Niya MH; Tameshkel FS; Sohrabi MR; Babaee MR; Rezvani H; Bahar B; Imanzade F; Zamani F; Khonsari MR; Ajdarkosh H; Hemmasi G
    Asian Pac J Cancer Prev; 2016; 17(2):603-8. PubMed ID: 26925650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRAF V600E Mutations in Endometrial Adenocarcinoma.
    He M; Breese V; Hang S; Zhang C; Xiong J; Jackson C
    Diagn Mol Pathol; 2013 Mar; 22(1):35-40. PubMed ID: 23370429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis.
    Ma ES; Wong CL; Law FB; Chan WK; Siu D
    J Clin Pathol; 2009 Oct; 62(10):886-91. PubMed ID: 19783717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.
    Karim B; Florence C; Kamel R; Nadia K; Ines O; Raja M; Sarra BJ; Florent S; Amel BA
    Cancer Biomark; 2010-2011; 8(6):331-40. PubMed ID: 22072121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
    Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
    PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demographic trends and KRAS/BRAF
    Fu X; Huang Y; Fan X; Deng Y; Liu H; Zou H; Wu P; Chen Z; Huang J; Wang J; Lin H; Huang S; Tan X; Lan P; Wang L; Wang JP
    Int J Cancer; 2019 May; 144(9):2109-2117. PubMed ID: 30414169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KRas and BRaf mutational status analysis from formalin-fixed, paraffin-embedded tissues using multiplex polymerase chain reaction-based assay.
    Jakubauskas A; Griskevicius L
    Arch Pathol Lab Med; 2010 Apr; 134(4):620-4. PubMed ID: 20367313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing.
    Mack E; Stabla K; Riera-Knorrenschild J; Moll R; Neubauer A; Brendel C
    BMC Cancer; 2016 Aug; 16():585. PubMed ID: 27485514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high-resolution melting analysis.
    Kristensen LS; Andersen GB; Hager H; Hansen LL
    Hum Mutat; 2012 Jan; 33(1):264-71. PubMed ID: 21901793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.